NCT05438914 (Subscap) is a NA clinical trial of Repair of the subscapularis in Rotator Cuff Tear Arthropathy, sponsored by Arthrex, Inc..

Who is sponsoring NCT05438914?

NCT05438914 is sponsored by Arthrex, Inc..

What drugs are being tested in NCT05438914?

Interventions in NCT05438914: Repair of the subscapularis.

What condition does NCT05438914 study?

NCT05438914 studies Rotator Cuff Tear Arthropathy.

Is NCT05438914 still recruiting?

NCT05438914 is currently status unknown. Last updated 30 January 2024.

Last reviewed 2024-01-30 · How we verify

NCT05438914: Subscap

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Subscapularis Repair in Reverse Shoulder Arthroplasty

Status unknown NA Last updated 30 January 2024

What this trial tests

NA trial testing Repair of the subscapularis in Rotator Cuff Tear Arthropathy in 134 participants. Status unknown.

Timeline

14 November 2022

Primary endpoint
14 September 2025

14 September 2025

Quick facts

Lead sponsor	Arthrex, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	134
Start date	14 November 2022
Primary completion	14 September 2025
Estimated completion	14 September 2025
Sites	6 locations across United States

Drugs / interventions tested

Repair of the subscapularis

Conditions studied

Rotator Cuff Tear Arthropathy — all drugs for Rotator Cuff Tear Arthropathy →

Sponsor

Arthrex, Inc. — full company profile →

Who can join

Adults 18 to 100, any sex, with Rotator Cuff Tear Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the subscapularis repair versus non-repair during a reverse shoulder arthroplasty (RSA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rotator Cuff Tear Arthropathy

Currently open trials in the same condition.

NCT07255534 — Efficacy and Safety of Digital Therapeutics for Improving Shoulder Function After Rotator Cuff Repair · NA · recruiting
NCT05439850 — Bioinductive Patch for Full-Thickness Rotator Cuff Tears · Phase 4 · recruiting
NCT05067543 — Perform Humeral System Study · recruiting
NCT05002335 — Clinical and Radiological Outcomes of Medacta Shoulder System (BE) · active not recruiting
NCT04529798 — Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless · recruiting

Other Arthrex, Inc. trials

Trials by the same sponsor.

NCT05765266 — ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial · NA · completed
NCT05981833 — Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears · recruiting
NCT05491564 — SoftStitch™ for All-Inside Meniscal Repair: Comparative Analysis of Patient Reported Outcome Measures · unknown
NCT05314608 — Knee Related Subchondral Bone Lesions Treated With IOBP · recruiting
NCT05046600 — Registry of Arthrex Hand and Wrist Products · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05438914 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arthrex, Inc.
Last refreshed: 30 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05438914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing